BSE: AARTIDRUGS - Aarti Drugs Limited

Lønnsomhet i seks måneder: -21.16%

Kampanjeplan Aarti Drugs Limited


Om selskapet

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.

flere detaljer
The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, moxifloxacin, norfloxacin, ofloxacin, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, benzene sulphonic acid methyl ester, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for the antioxidant, antifungal, cardiovascular, and antidiabetic therapeutic areas. The company was incorporated in 1984 and is headquartered in Mumbai, India.

ISIN INE767A01016
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.1895
Дивиденд ао 1
Сайт https://www.aartidrugs.co.in
Цена ао 422.65
Prisendring per dag: -0.5915% (422.65)
Prisendring per uke: -7.97% (456.55)
Prisendring per måned: -5.57% (444.95)
Prisendring over 3 måneder: -16.81% (505.05)
Prisendring over seks måneder: -21.16% (532.9)
Prisendring per år: -21.08% (532.35)
Prisendring over 3 år: -20.53% (528.7)
Prisendring over 5 år: -19.25% (520.3)
Prisendring over 10 år: 0% (420.15)
Prisendring siden begynnelsen av året: -3.01% (433.2)

Undervurdering

Navn Betydning Karakter
P/S 1.66 8
P/BV 3.27 5
P/E 24.43 6
EV/EBITDA 12.94 7
Total: 6.75

Effektivitet

Navn Betydning Karakter
ROA, % 7.06 2
ROE, % 13.86 4
Total: 3.67

Utbytte

Navn Betydning Karakter
Div yield, % 0.1895 0.48
DSI 0.9286 9.29
Total: 1.61

Plikt

Navn Betydning Karakter
Debt/EBITDA 1.83 7
Total: 7.4

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 40 6
Lønnsomhet Ebitda, % 44.13 6
Lønnsomhet EPS, % -43.02 0
Total: 3.2

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares MSCI India Small-Cap ETF 0.05202 0.4625 0.96163
WisdomTree India Earnings Fund 0.03922 5.23 1.65591
SPDR S&P Emerging Markets Small Cap ETF 0.02285 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.02276 7.67 2.7853
Dimensional Emerging Markets Core Equity 2 ETF 0.00727 15.96 3.34087
SPDR Portfolio MSCI Global Stock Market ETF 0.00571 17.99 2.19607
Avantis Emerging Markets Equity ETF 0.00091 8.77 3.60513
SPDR Portfolio Emerging Markets ETF 0.0009 11.59 3.1879

Veileder Stillingstittel Betaling Fødselsår
Mr. Prakash Moreshwar Patil Chairman, MD, CEO & Head of BR 27.65M 1947 (78 år)
Mr. Harshit Manila Savla Joint MD & Executive Director 25.55M 1962 (63 år)
Mr. Harit Pragji Shah Whole-Time Director 25.55M 1963 (62 år)
Mr. Uday Moreshwar Patil Whole-Time Director 3.19M 1963 (62 år)
Mr. Rashesh Chandrakant Gogri MD & Executive Director 25.55M 1974 (51 år)
Mr. Adhish Prakash Patil CFO & COO N/A 1983 (42 år)
Mr. Dhanaji L. Kakade Vice President of Technical N/A
Mr. Vishwa Harshit Savla Managing Director of the Pinnacle Life Science Private Limited N/A
Mr. Rushikesh Vivek Deole Company Secretary & Compliance Officer N/A

Adresse: India, Mumbai, Mahendra Industrial Estate - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.aartidrugs.co.in